All lobbying filings

RED+BLUE STRATEGIES

RED+BLUE STRATEGIES filed a Q3 report for PRIME THERAPEUTICS on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for PRIME THERAPEUTICS · Pharmacy solutions partner for health plans and employers.

All filings by RED+BLUE STRATEGIES · Everything PRIME THERAPEUTICS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Minnesota

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to Pharmacy Benefit Managers and Medicare Part D.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.